These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Finding the right job for the tool: alemtuzumab and its role in renal transplantation. Newell KA; Cendales LC; Kirk AD Am J Transplant; 2008 Jul; 8(7):1363-4. PubMed ID: 18557735 [No Abstract] [Full Text] [Related]
17. [Monoclonal antibodies in renal transplantation]. Bonvoisin C; Weekers L; Grosch S; Krzesinski JM Rev Med Liege; 2009; 64(5-6):287-92. PubMed ID: 19642461 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation. Farney A; Sundberg A; Moore P; Hartmann E; Rogers J; Doares W; Jarrett A; Adams P; Stratta R Clin Transplant; 2008; 22(1):41-9. PubMed ID: 18217904 [TBL] [Abstract][Full Text] [Related]
19. Rabbit antithymocyte globulin or basiliximab for induction therapy? Josephson MA N Engl J Med; 2006 Nov; 355(19):2033-5. PubMed ID: 17093255 [No Abstract] [Full Text] [Related]
20. Induction therapy in pediatric kidney transplant recipients discharged with a triple drug immunosuppressive regimen. Sampaio MS; Poommipanit N; Kuo HT; Reddy PN; Cho YW; Shah T; Bunnapradist S Pediatr Transplant; 2010 Sep; 14(6):770-8. PubMed ID: 20477974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]